A carregar...
Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy – A pilot study
OBJECTIVES: Spinal muscular atrophy is a monogenic disease characterized by progressive spinal and bulbar muscle weakness and atrophy. It is caused by the degeneration of alpha-motoneurons. The recent approval of the antisense oligonucleotide nusinersen highlights the need for reliable clinical tool...
Na minha lista:
| Publicado no: | Acta Myol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pacini Editore Srl
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7460731/ https://ncbi.nlm.nih.gov/pubmed/32904902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36185/2532-1900-010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|